Skip to main content

Advertisement

SpringerLink
Log in

Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Purpose

The efficacy and safety of sublingual immunotherapy (SLIT) in house dust mite-induced allergic asthma (AA) have yet to be firmly established, especially in adult patients. Our objective is to evaluate the efficacy of SLIT with Dermatophagoides farinae drops in adult patients with AA.

Methods

One hundred and thirty-four adult patient data with house dust mite (HDM)-induced AA who had been treated for 2 years were collected. These patient data that we collected were divided into the SLIT group (n = 85) and control group (n = 49). All patients were treated with low to moderate dose of inhaled glucocorticoid and long-acting β2 agonists. Patients in the SLIT group were further treated with D. farinae drops. Clinical scores including the total asthma symptom score (TASS), total asthma medicine score (TAMS), asthma control test (ACT), and peak flow percentage (PEF%) were assessed before treatment and at yearly visits. The presence of adverse events (AEs) were recorded once a month.

Results

Before treatment, the PEF% in the SLIT group was significantly lower than that in the control group (p < 0.05). After 2 years, both treatments were effective in the clinical scores when compared with baseline values (all p < 0.001). Meanwhile, the SLIT group showed significantly lower TASS and TAMS (all p < 0.001) and higher ACT (p < 0.001) and PEF% (p < 0.05) when compared with the control group. No severe systemic AEs were reported.

Conclusions

SLIT with D. farinae drops plus pharmacotherapy is more effective than routine drug treatment in adult patients with AA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yukselen A, Kendirli SG (2014) Role of immunotherapy in the treatment of allergic asthma. World J Clin Cases: WJCC 2(12):859. 10.12998/wjcc.v2.i12.859

    Article  PubMed  PubMed Central  Google Scholar 

  2. The global asthma report 2014. Available at: http://www.globalasthmareport.org/burde-n/burden.php

  3. Masoli M, Fabian D, Holt S et al (2004) Global burden of asthma. Allergy 59:469–478

    Article  PubMed  Google Scholar 

  4. Knudsen TB, Thomsen SF, Nolte H et al (2009) A population-based clinical study of allergic and non-allergic asthma. J Asthma 46:91–94. https://doi.org/10.1080/02770900802524657

    Article  PubMed  Google Scholar 

  5. Zureik M, Neukirch C, Leynaert B et al (2002) Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community Respiratory Health Survey. BMJ 325:411–414

    Article  PubMed  PubMed Central  Google Scholar 

  6. Masoli M, Fabian D, Holt S et al (2004) The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy 59:469–478. https://doi.org/10.1111/j.1398-9995.2004.00526.x

    Article  PubMed  Google Scholar 

  7. Li J, Sun B, Huang Y et al (2009) A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. Allergy 64:1083–1092. https://doi.org/10.1111/j.1398-9995.2009.01967.x

    Article  CAS  PubMed  Google Scholar 

  8. Platts-Mills TAE, Erwin EA, Heymann PW et al (2009) Pro: the evidence for a causal role of dust mites in asthma. Am J Respir Crit Care Med 180:109–121. https://doi.org/10.1164/rccm.200811-1756PR

    Article  PubMed  Google Scholar 

  9. Li J, Sun B, Huang Y et al (2009) A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China. Allergy 64(7):1083–1092. https://doi.org/10.1111/j.1398-9995.2009.01967.x

    Article  CAS  PubMed  Google Scholar 

  10. Lind P, Hansen OC, Horn N (1988) The binding of mouse hybridoma and human IgE antibodies to the major fecal allergen, der p I, of Dermatophagoides pteronyssinus. Relative binding site location and species specificity studied by solid-phase inhibition assays with radiolabeled antigen. J Immunol 140(12):4256–4262

    CAS  PubMed  Google Scholar 

  11. Thomas WR, Smith WA, Hales BJ et al (2002) Characterization and immunobiology of house dust mite allergens. Int Arch Allergy Immunol 129(1):1

    Article  CAS  PubMed  Google Scholar 

  12. Yasueda H, Mita H, Yui Y et al (1989) Comparative analysis of physicochemical and immunochemical properties of the two major allergens from Dermatophagoides pteronyssinus and the corresponding allergens from Dermatophagoides farinae. Int Arch Allergy Appl Immunol 88(4):402–407

    Article  CAS  PubMed  Google Scholar 

  13. Bousquet J, Lockey R, Malling HJ (1998) World Health Organization position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53(Suppl. 44):1–42

    Google Scholar 

  14. Akdis CA, Akdis M (2011) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 127:18–27

    Article  CAS  PubMed  Google Scholar 

  15. Akdis CA (2012) Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 18:736–749

    Article  CAS  PubMed  Google Scholar 

  16. Calamita Z, Saconato H, Pela AB et al (2006) Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the Cochrane collaboration method. Allergy 61:1162–1172. https://doi.org/10.1111/j.1398-9995.2006.01205.x

    Article  CAS  PubMed  Google Scholar 

  17. Compalati E, Passalacqua G, Bonini M et al (2009) The efficacy of sublingual immunotherapy for house dust mite respiratory allergy: results of a GA2LEN meta-analysis. Allergy 64:1570–1579. https://doi.org/10.1111/j.1398-9995.2009.02129.x

    Article  CAS  PubMed  Google Scholar 

  18. Canonica GW, Bousquet J, Casale T et al (2009) Sub-lingual immunotherapy: World Allergy Organization position paper 2009. Allergy 64(Suppl. 91):1–59. https://doi.org/10.1111/j.1398-9995.2009.02309.x

    PubMed  Google Scholar 

  19. Radulovic S, Wilson D, Calderon M et al (2011) Systematic reviews of sublingual immunotherapy (SLIT). Allergy 66:740–752. https://doi.org/10.1111/j.1398-9995.2011.02583.x

    Article  CAS  PubMed  Google Scholar 

  20. Global Initiative for Asthma (GINA) Executive Committee (2006) Global strategy for asthma management and prevention 1–110

  21. Wang H, Lin X, Hao C et al (2006) A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy 61:191–197. https://doi.org/10.1111/j.1398-9995.2005.00913.x

    Article  CAS  PubMed  Google Scholar 

  22. Pfaar O, Demoly P, Gerth van Wijk R et al (2014) Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper. Allergy 69(7):854–867. https://doi.org/10.1111/all.12383

    Article  CAS  PubMed  Google Scholar 

  23. Schlosser RJ, Smith TL, Mace J et al (2016) Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis. Allergy. https://doi.org/10.1111/all.13048

  24. Abramson MJ, Puy RM, Weiner JM (1995) Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 151:969–974. https://doi.org/10.1164/ajrccm.152.5.7582321

    CAS  PubMed  Google Scholar 

  25. Ross RN, Nelson HS, Finegold I (2000) Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Ther 22:329–341. https://doi.org/10.1016/S0149-2918(00)80037-5

    Article  CAS  PubMed  Google Scholar 

  26. Pifferi M, Baldini G, Marrazzini G et al (2002) Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 57:785–790

    Article  CAS  PubMed  Google Scholar 

  27. Basomba A, Tabar AI, de Rojas DH et al (2002) Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients. J Allergy Clin Immunol 109:943–948

    Article  PubMed  Google Scholar 

  28. García-Robaina JC, Sánchez I, de la Torre F et al (2006) Successful management of mite-allergicasthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study. J Allergy Clin Immunol 118:1026–1032. https://doi.org/10.1016/j.jaci.2006.07.043

    Article  PubMed  Google Scholar 

  29. Wang L, Yin J, Fadel R et al (2014) House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma. Allergy 69(9):1181–1188. https://doi.org/10.1111/all.12188

    Article  CAS  PubMed  Google Scholar 

  30. Mosbech H, Deckelmann R, De Blay F et al (2014) Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 134:568–575. https://doi.org/10.1016/j.jaci.2014.03.019

    Article  CAS  PubMed  Google Scholar 

  31. Virchow JC (2016) Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma. JAMA 315:1715–1725. https://doi.org/10.1001/jama.2016.3964

    Article  CAS  PubMed  Google Scholar 

  32. Shao J, Cui YX, Zheng YF et al (2014) Efficacy and safety of sublingual immunotherapy in children aged 3-13 years with allergic rhinitis. Am J Rhinol Allergy 28(2):131. https://doi.org/10.2500/ajra.2014.28.4006

    Article  PubMed  Google Scholar 

  33. Li P, Li Q, Huang Z et al (2014) Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases[C]. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.21397

  34. Keles S, Karakoc-Aydiner E, Ozen A et al (2011) A novel approach inallergen-specific immunotherapy: combination of sublingual and subcutaneous routes. J Allergy Clin Immunol 128:808–815. https://doi.org/10.1016/j.jaci.2011.04.033

    Article  CAS  PubMed  Google Scholar 

  35. Dahl R, Stender A, Rak S (2006) Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 61:185–190. https://doi.org/10.1111/j.1398-9995.2005.00949.x

    Article  CAS  PubMed  Google Scholar 

  36. Moral A, Moreno V, Girón F et al (2016) Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy. J Asthma Allergy 9:129–133. https://doi.org/10.2147/JAA.S107830

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the patients for their availability in taking part in this trial.

Funding

All financial supports for this clinical trial were provided by the Department of Science and Technology project of Wuzhou City, Guangxi Province, China (Contract No. 201202081).

Author information

Authors and Affiliations

  1. Department of Respiratory, Wuzhou Red Cross Hospital, No.1-3 Xinxingyi road, Dieshan district, Wuzhou, 543002, China

    C. Zhong, W. Yang, Y. Li, L. Zou, Z. Deng, M. Liu & X. Huang

Authors
  1. C. Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Z. Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. X. Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Zhong.

Ethics declarations

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhong, C., Yang, W., Li, Y. et al. Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma. Ir J Med Sci 187, 441–446 (2018). https://doi.org/10.1007/s11845-017-1685-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-017-1685-x

Keywords

Search

Navigation